Effectiveness of lenalidomide in a patient with refractory anemia with ring sideroblasts and thrombocytosis with JAK2 (V617F) mutation

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|8|E148-E149

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.8, 2015-08, pp. : E148-E149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Refractory anemia with ring sideroblasts and RARS with thrombocytosis

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 549-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Melting Point Assay for the JAK2 V617F Mutation, Comparison with Amplification Refractory Mutation System (ARMS) in Diagnostic Samples, and Implications for Daily Routine

By Ochsenreither Sebastian   Reinwald Mark   Thiel Eckhard   Burmeister Thomas  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 3, 2010-06 ,pp. : 185-190

Adis International

Access to resources Recommend Favorite

Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 148-159

Karger

Access to resources Recommend Favorite

Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis?

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 49-56

Karger

Access to resources Recommend Favorite

Presence of the JAK2 V617F Mutation in a Patient with Chronic Neutrophilic Leukemia and Effective Response to Interferon Alfa-2b

By  

Acta Haematologica, Vol. 130, Iss. 1, 2013-02 ,pp. : 44-46

Karger

Access to resources Recommend Favorite